ranfac.com

What It Is

Ranfac Corporation is a medical device manufacturer based in Avon, Massachusetts, USA, not a SaaS or enterprise software company. It positions itself as a “single-source” manufacturing platform for subcutaneous injection/puncture medical devices, starting from raw metals and polymers and handling metal fabrication, plastic molding, cleanroom assembly, EO sterilization, and sterile packaging. Founded in 1888, the company states on its website that its 40,000-square-foot facility produces more than 600,000 sterile finished products per year.

Core Capabilities

Ranfac’s core offering is not software modules, but medical device CDMO/CMO manufacturing capabilities. On the metal side, it offers 12 types of processes, including cutting, point grinding, welding, etching, CNC machining, TIG welding, and electropolishing. On the plastics side, it supports Class 8 cleanroom injection molding, insert molding, and overmolding. Assembly is performed in a Class 7 cleanroom, with batch traceability enabled through ERP barcode scanning. In partnership with STERIS, it provides pre-validated EO sterilization and manages validation, testing, and logistics. On the compliance side, the site lists ISO 13485:2016, MDSAP, EU MDR, FDA Registered, 21 CFR 820, and FDA CFG.

Pricing and Engagement Model

The website does not publish pricing and does not offer SaaS-style plans. Engagement models include CDMO services from “concept to approval,” CMO services from “approved to scale,” as well as procurement of its own OEM products. Ranfac emphasizes low minimum order quantities and the ability to scale from an initial production run to more than 500,000 units per year. Buyers can request quotes, samples, and technical assessments.

Pros and Cons

The advantages are its high degree of vertical integration, which reduces transfers across multiple suppliers and fragmentation between quality systems. It is well suited for Class I/II device projects that require integrated metal and plastic manufacturing, sterile finished product delivery, and regulatory support. Its in-house bone marrow aspiration, SNARECOIL biopsy, and general surgery product lines also provide supporting evidence of process validation. The limitations are that its business scope is very narrow: it is not suitable for Class III implants, purely electronic/IVD/software products, non-medical industrial components, or mass-market needle products at the million-unit-plus level. Costs, lead times, and service SLAs are also not disclosed.

Who It’s For and Access from China

Ranfac is suitable for U.S. or EU OEMs, medical device startups, and minimally invasive puncture-device companies that need U.S.-based manufacturing and a global compliance pathway. The review text does not provide information about access from China, so this cannot be determined.